|
Volumn 15, Issue 10, 2009, Pages 1127-1130
|
Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: a randomized and placebo-controlled clinical trial.
a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALBUMINOID;
ALPHA INTERFERON;
ANTINEOPLASTIC AGENT;
FLUOROURACIL;
HAISHENGSU;
HERBACEOUS AGENT;
INTERLEUKIN 2;
PLANT EXTRACT;
ADJUVANT CHEMOTHERAPY;
ANIMAL;
ARTICLE;
BIVALVE;
CALORIC INTAKE;
CHEMISTRY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
FEMALE;
GASTROINTESTINAL TRACT;
HUMAN;
KARNOFSKY PERFORMANCE STATUS;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
WEIGHT GAIN;
ALBUMINS;
ANIMALS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARCIDAE;
CARCINOMA, RENAL CELL;
CHEMOTHERAPY, ADJUVANT;
DRUGS, CHINESE HERBAL;
ENERGY INTAKE;
FEMALE;
FLUOROURACIL;
GASTROINTESTINAL TRACT;
HUMANS;
INTERFERON-ALPHA;
INTERLEUKIN-2;
KARNOFSKY PERFORMANCE STATUS;
KIDNEY NEOPLASMS;
MALE;
MIDDLE AGED;
PLANT EXTRACTS;
REMISSION INDUCTION;
WEIGHT GAIN;
|
EID: 76249125481
PISSN: None
EISSN: 15577708
Source Type: Journal
DOI: 10.1089/acm.2009.0260 Document Type: Article |
Times cited : (10)
|
References (0)
|